Showing results (131-140 of 156) with videos related to
Sort By:
Pageof 16
Pharmaceuticals (Basel, Switzerland)|August 28, 2025
Correction: Wang et al. Antiproliferative and Tubulin-Destabilising Effects of 3-(Prop-1-en-2-yl)azetidin-2-Ones and Related Compounds in MCF-7 and MDA-MB-231 Breast Cancer Cells. Pharmaceuticals 2023, 16, 1000Shu Wang, Azizah M Malebari, Thomas F Greene, et al.Frontiers in Toxicology|July 25, 2024
Bioactivation of cinnamic alcohol in a reconstructed human epidermis model and evaluation of sensitizing potency of the identified metabolitesLorena Ndreu, Josefine Carlsson, David J Ponting, et al.Organic & Biomolecular Chemistry|June 8, 2019
Synthesis and evaluation of antiproliferative microtubule-destabilising combretastatin A-4 piperazine conjugatesNiamh M O'Boyle, Gloria Ana, Patrick M Kelly, et al.European Journal of Medicinal Chemistry|August 16, 2011
Synthesis, biochemical and molecular modelling studies of antiproliferative azetidinones causing microtubule disruption and mitotic catastropheNiamh M O'Boyle, Miriam Carr, Lisa M Greene, et al.Pharmaceuticals (Basel, Switzerland)|July 29, 2023
Antiproliferative and Tubulin-Destabilising Effects of 3-(Prop-1-en-2-yl)azetidin-2-Ones and Related Compounds in MCF-7 and MDA-MB-231 Breast Cancer CellsShu Wang, Azizah M Malebari, Thomas F Greene, et al.Journal of Medicinal Chemistry|April 21, 2017
Lead Optimization of Benzoxepin-Type Selective Estrogen Receptor (ER) Modulators and Downregulators with Subtype-Specific ERα and ERβ ActivityNiamh M O'Boyle, Irene Barrett, Lisa M Greene, et al.Pharmaceuticals (Basel, Switzerland)|November 27, 2021
Synthesis and Antiproliferative Evaluation of 3-Chloroazetidin-2-ones with Antimitotic Activity: Heterocyclic Bridged Analogues of Combretastatin A-4Azizah M Malebari, Shu Wang, Thomas F Greene, et al.Pharmaceuticals (Basel, Switzerland)|August 28, 2025
Correction: Malebari et al. Synthesis and Antiproliferative Evaluation of 3-Chloroazetidin-2-ones with Antimitotic Activity: Heterocyclic Bridged Analogues of Combretastatin A-4. Pharmaceuticals 2021, 14, 1119Azizah M Malebari, Shu Wang, Thomas F Greene, et al.Pharmaceuticals (Basel, Switzerland)|April 14, 2019
3-Vinylazetidin-2-Ones: Synthesis, Antiproliferative and Tubulin Destabilizing Activity in MCF-7 and MDA-MB-231 Breast Cancer CellsShu Wang, Azizah M Malebari, Thomas F Greene, et al.Pharmaceuticals (Basel, Switzerland)|November 18, 2020
Potent Quinoline-Containing Combretastatin A-4 Analogues: Design, Synthesis, Antiproliferative, and Anti-Tubulin ActivityTarek S Ibrahim, Mohamed M Hawwas, Azizah M Malebari, et al.Pageof 16